Kolon TissueGene Showcases Landmark Safety Data for TG-C at OARSI World Congress Kolon TissueGene presented promising long-term safety results for its TG-C therapy at the OARSI World Congress, potentially paving the way for U.S. FDA approval.

Kolon TissueGene Showcases Landmark Safety Data for TG-C at OARSI World Congress #South_Korea #Kolon_TissueGene #TG-C #OARSI #Songdo